Direxion Daily S&P Biotech Bear 3X ETF (LABD)
6.40
+0.47 +7.93%
NYSE Arca
Jul 27, 16:59
Delayed 2m
USD
LABD Key Stats
| Expense Ratio | 1.08% |
| Share Class Assets Under Management | 110.88M |
| 30-Day Average Daily Volume | Upgrade |
| Net Asset Value | 5.95 |
| Discount or Premium to NAV | -0.34% |
| Turnover Ratio | 0.00 |
View All LABD News
LABD News
-
WireHeadlineTime (ET)
-
Yahoo07/13 11:00
-
SA Breaking News07/06 15:09
-
Yahoo06/30 11:38
-
Yahoo06/28 10:45
-
SA Breaking News06/26 04:46
-
SA Breaking News06/21 19:22
-
SA Breaking News06/07 14:02
-
SA Breaking News03/24 16:02
-
SA Breaking News03/02 13:20
-
SA Breaking News03/01 10:11
LABD Performance
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | -5.12% | -- | -- |
| 3M | -39.61% | -- | -- |
| 6M | -61.34% | -- | -- |
| 1Y | -77.21% | -- | -- |
| 3Y | -- | -- | -- |
| 5Y | -- | -- | -- |
| 10Y | -- | -- | -- |
LABD Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 97.30% | 109.6% | 12.29% |
| Stock | -8.11% | 0.00 | 8.11% |
| Bond | 23.57% | 23.57% | 0.00 |
| Convertible | 0.00 | 0.00 | 0.00 |
| Preferred | 0.00 | 0.00 | 0.00 |
| Other | -12.76% | 0.00 | 12.76% |
LABD Region Exposure
| Americas | 100.0% |
| North America | 100.0% |
| Latin America | 0.00 |
| Greater Europe | 0.00 |
| United Kingdom | 0.00 |
| Europe Developed | 0.00 |
| Europe Emerging | 0.00 |
| Africa/Middle East | 0.00 |
| Greater Asia | 0.00 |
| Japan | 0.00 |
| Australasia | 0.00 |
| Asia Developed | 0.00 |
| Asia Emerging | 0.00 |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00 |
LABD Stock Sector Exposure
| Basic Materials | 0.00 |
| Communication Services | 0.00 |
| Consumer Cyclical | 0.00 |
| Consumer Defensive | 0.00 |
| Energy | 0.00 |
| Financial Services | 0.00 |
| Healthcare | 0.00 |
| Industrials | 0.00 |
| Real Estate | 0.00 |
| Technology | 0.00 |
| Utilities | 0.00 |
LABD Stock Market Capitalization
| Giant | -- |
| Large | -- |
| Medium | -- |
| Small | -- |
| Micro | -- |
LABD Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Blend | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Blend | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Blend | -- |
| Small Cap Growth | -- |
LABD Bond Exposure
| Government | 0.00 |
| Corporate | 0.00 |
| Securitized | 0.00 |
| Municipal | 0.00 |
| Cash | 100.0% |
| Derivative | 0.00 |
LABD Bond Credit Quality Exposure
| AAA | -- |
| AA | -- |
| A | -- |
| BBB | -- |
| BB | -- |
| B | -- |
| Below B | -- |
LABD Bond Maturity Exposure
| 1 to 7 Days | 0.00 |
| 8 to 30 Days | 0.00 |
| 31 to 90 Days | 0.00 |
| 91 to 182 Days | 0.00 |
| 183 to 364 Days | 0.00 |
| 1 to 3 Years | 0.00 |
| 3 to 5 Years | 0.00 |
| 5 to 7 Years | 0.00 |
| 7 to 10 Years | 0.00 |
| 10 to 15 Years | 0.00 |
| 15 to 20 Years | 0.00 |
| 20 to 30 Years | 0.00 |
| Over 30 Years | 100.0% |
View More Holdings
As of June 30, 2017
LABD Top 4 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| -- | Fidelity Institutional Go | 23.57% | -- | -- |
| -- | S&P Biotechnology Select | 12.70% | -- | -- |
| -- | S&P Biotechnology Select Industry USD | 8.12% | -- | -- |
| -- | S&P Biotechnology Select | 0.05% | -- | -- |
Advertisement
LABD One Page Reports
- One Page Report Download
LABD Basic Info
| Style | |
|---|---|
| Broad Asset Class | Alternative |
| Broad Category | Alternative |
| Category Name | Trading--Inverse Equity |
| Prospectus Objective | Specialty - Technology |
| Fund Owner Firm Name | Direxion Funds |
| Benchmark Index | |
|---|---|
S&P Biotechnology Select Industry TR USD |
-300.0% |
LABD Manager Info
| Name | Tenure |
|---|---|
| Paul Brigandi | 1.93 yrs |
| Tony Ng | 1.59 yrs |
LABD Net Fund Flows
| 1M | 63.60M |
| 3M | 32.73M |
| 6M | 123.86M |
| YTD | 123.86M |
| 1Y | 149.03M |
| 3Y | -- |
| 5Y | -- |
| 10Y | -- |
LABD Risk Info
| Beta (5Y) | -- |
| Max Drawdown (All) | 93.33% |
| Historical Sharpe (10Y) | -- |
| Historical Sortino (All) | -0.3666 |
| 30-Day Rolling Volatility | 78.88% |
| Daily Value at Risk (VaR) 1% (All) | 15.39% |
| Monthly Value at Risk (VaR) 1% (All) | 42.10% |
LABD Fundamentals
| General | |
|---|---|
| Dividend Yield TTM (7-27-17) | 0 |
| SEC Yield | -- |
| Forecasted Dividend Yield | -- |
| Number of Holdings | 10 |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Forecasted PE Ratio | -- |
| Forecasted PS Ratio | -- |
| Forecasted Price to Book Value | -- |
| Number of Stock Holdings | 0 |
| Bond | |
| Current Yield | -- |
| Yield to Maturity | -- |
| Effective Duration | -- |
| Average Coupon | 0.82% |
| Average Credit Score | -- |
| Average Price | 100.00 |
| Number of Bond Holdings | 1 |
LABD Comparables
EditLABD Attributes
| Key Dates | |
|---|---|
| Inception Date | 5/28/2015 |
| Last Annual Report Date | 10/31/2016 |
| Last Prospectus Date | 2/28/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | Yes |
| Leveraged Fund | Yes |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
LABD Excel Add-In Codes
- Name: =YCI("LABD","name")
- Broad Asset Class: =YCI("LABD", "broad_asset_class")
- Broad Category: =YCI("LABD", "broad_category_group")
- Prospectus Objective: =YCI("LABD", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
